Nanoform

Nanoform Contract Manufacturing & Development (CDMO) Profile

Nanoform is the medicine performance-enhancing company that leverages best-in-class innovative nanoparticle engineering technologies, expert formulation, and scalable GMP nano-API manufacturing to enable superior medicines for patients. The company focuses on reducing clinical attrition and on enhancing drug molecules’ performance through its nanoforming technologies and formulation services, from pre-clinical to commercial scale. Nanoform will help improve bioavailability and drug delivery profiles, drive differentiation, patient adherence and extend the lifecycle potential of products.

CDMO Services:
Small Molecule; Biologics Drug Substance Manufacturing (API); Drug Product Formulation (FDF); Research & Development; Clinical Trials materials and logistics; Analytical Development

Year Founded: 2015

Head Office: Helsinki, Finland

Number of Facilities: 1

Facility locations: Europe

Website: Visit the Nanoform website

Linkedin: Connect on Linkedin

Current Capacity: Nanoform have recently tripled GMP manufacturing capacity to meet the growing interest in nanoparticle formulations. Nanoform have high potent capacity down to 30ng/m3 OEL and can manufacture the worlds smallest API particles (down to 10nm) and create valuable drug product formulations for our Pharma and Biotech partners.